These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34402784)

  • 1. Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea.
    Ronnebaum S; Bron M; Patel D; Menno D; Bujanover S; Kratochvil D; Lucas E; Stepnowsky C
    J Clin Sleep Med; 2021 Dec; 17(12):2543-2555. PubMed ID: 34402784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Efficacy and Safety of Wakefulness-Promoting Agents for Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea : A Systematic Review and Network Meta-analysis.
    Pitre T; Mah J; Roberts S; Desai K; Gu Y; Ryan C; Busse JW; Zeraatkar D
    Ann Intern Med; 2023 May; 176(5):676-684. PubMed ID: 37155992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea.
    Malhotra A; Shapiro C; Pepin JL; Hedner J; Ahmed M; Foldvary-Schaefer N; Strollo PJ; Mayer G; Sarmiento K; Baladi M; Chandler P; Lee L; Schwab R
    Sleep; 2020 Feb; 43(2):. PubMed ID: 31691827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study.
    Inoue Y; Takasaki Y; Yamashiro Y
    J Clin Sleep Med; 2013 Aug; 9(8):751-7. PubMed ID: 23946704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial.
    Schweitzer PK; Rosenberg R; Zammit GK; Gotfried M; Chen D; Carter LP; Wang H; Lu Y; Black J; Malhotra A; Strohl KP;
    Am J Respir Crit Care Med; 2019 Jun; 199(11):1421-1431. PubMed ID: 30521757
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy.
    Rosenberg R; Thorpy MJ; Dauvilliers Y; Schweitzer PK; Zammit G; Gotfried M; Bujanover S; Scheckner B; Malhotra A
    J Clin Sleep Med; 2022 Jan; 18(1):235-244. PubMed ID: 34283019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating pharmacological treatments for excessive daytime sleepiness in obstructive sleep apnea: A comprehensive network meta-analysis and systematic review.
    Neshat SS; Heidari A; Henriquez-Beltran M; Patel K; Colaco B; Arunthari V; Lee Mateus AY; Cheung J; Labarca G
    Sleep Med Rev; 2024 Aug; 76():101934. PubMed ID: 38754208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in OSA: An Analysis of Subgroups Adherent or Nonadherent to OSA Treatment.
    Schweitzer PK; Mayer G; Rosenberg R; Malhotra A; Zammit GK; Gotfried M; Chandler P; Baladi M; Strohl KP
    Chest; 2021 Jul; 160(1):307-318. PubMed ID: 33631141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression.
    Krystal AD; Benca RM; Rosenberg R; Schweitzer PK; Malhotra A; Babson K; Lee L; Bujanover S; Strohl KP
    J Psychiatr Res; 2022 Nov; 155():202-210. PubMed ID: 36070638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study.
    Schwartz JR; Hirshkowitz M; Erman MK; Schmidt-Nowara W
    Chest; 2003 Dec; 124(6):2192-9. PubMed ID: 14665500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Modafinil and Armodafinil in Patients With Obstructive Sleep Apnea: A Meta-analysis of Randomized Controlled Trials.
    Kuan YC; Wu D; Huang KW; Chi NF; Hu CJ; Chung CC; Tam KW; Huang YH
    Clin Ther; 2016 Apr; 38(4):874-88. PubMed ID: 26923035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically relevant effects of solriamfetol on excessive daytime sleepiness: a posthoc analysis of the magnitude of change in clinical trials in adults with narcolepsy or obstructive sleep apnea.
    Rosenberg R; Baladi M; Bron M
    J Clin Sleep Med; 2021 Apr; 17(4):711-717. PubMed ID: 33226332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solriamfetol for the Treatment of Excessive Sleepiness in OSA: A Placebo-Controlled Randomized Withdrawal Study.
    Strollo PJ; Hedner J; Collop N; Lorch DG; Chen D; Carter LP; Lu Y; Lee L; Black J; Pépin JL; Redline S;
    Chest; 2019 Feb; 155(2):364-374. PubMed ID: 30471270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
    Black JE; Hirshkowitz M
    Sleep; 2005 Apr; 28(4):464-71. PubMed ID: 16171291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
    J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of solriamfetol for excessive sleepiness in narcolepsy and obstructive sleep apnea: findings from randomized controlled trials.
    Wang J; Yang S; Li X; Wang T; Xu Z; Xu X; Gao H; Chen G
    Sleep Med; 2021 Mar; 79():40-47. PubMed ID: 33472129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Wakefulness-Promoting Agents on Sleepiness in Patients with Sleep Apnea Treated with CPAP: A Meta-Analysis.
    Sukhal S; Khalid M; Tulaimat A
    J Clin Sleep Med; 2015 Oct; 11(10):1179-86. PubMed ID: 25979103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modafinil/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis.
    Chapman JL; Vakulin A; Hedner J; Yee BJ; Marshall NS
    Eur Respir J; 2016 May; 47(5):1420-8. PubMed ID: 26846828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of solriamfetol for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a systematic review and meta-analysis of clinical trials.
    Subedi R; Singh R; Thakur RK; K C B; Jha D; Ray BK
    Sleep Med; 2020 Nov; 75():510-521. PubMed ID: 33032062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.